IFN-α2b (recombinant human)

Ligand id: 8338

Name: IFN-α2b (recombinant human)

No information available.
Summary of Clinical Use
IFN-α2b is used clinically to treat hairy cell leukemia, malignant melanoma, follicular lymphoma, condylomata acuminata (anogenital warts), AIDS-related Kaposi's sarcoma, chronic hepatitis B and chronic hepatitis C.
Mechanism Of Action and Pharmacodynamic Effects
IFN-α2b activates interferon receptors to produce anti-viral, anti-proliferative, anti-tumor and immunomodulatory effects.